Dr. Yasuo Takeda, Chairman of the Japanese Society of Hospital Pharmacists, has been appointed as an advisor to our company.
Press
Tokushukai Group has introduced “StudyWorks®︎” for the first time in a group hospital.
Tokushukai Group is the first group hospital to introduce “StudyWorks®︎” to promote digital transformation in clinical trials.
Buzzreach Inc. (Head office: Minato-ku, Tokyo, CEO: Takateru Inokawa) is pleased to announce that its clinical trial and clinical research support management tool “StudyWorks®︎” has been introduced to Tokushukai Group, a general incorporated association (Location: Chiyoda, Tokyo).
Related Articles
-
-
New Year’s Greetings
-
Notice of New Year’s holiday closure and thanks for the year
-
Lecture report by the “StudyWorks®” Product Development Department Manager released – The challenge of developing a DCT platform in collaboration with clinical trial sites –
-
Published an article titled “Future Outlook for Digitalization of Clinical Trial Management: Considering the Benefits of Work Reduction Through System Use”
-
[Webinar] Eliminate the risk of not achieving your goals! “Regional Collaboration DCT” strategy to accelerate case registration
-
We will be exhibiting a corporate booth at the 57th Annual Meeting of the Japanese Society of Pediatric Respiratory Medicine.
-
Guidance and request for cooperation regarding the handling of clinical trial information when using the clinical trial support system “StudyWorks”
-
Published an article on the application of DCT (Decentralized Clinical Trials) in Japan and the future of DX in the clinical trial industry
-
Representative Ikawa will be speaking at the 22nd DIA Japan Annual Meeting 2025, and the company will have a booth.